Pathogenesis of liver cirrhosis

被引:716
作者
Zhou, Wen-Ce [1 ]
Zhang, Quan-Bao [2 ,3 ]
Qiao, Liang [4 ,5 ]
机构
[1] Lanzhou Univ, Hosp 1, Dept Gen Surg 2, Lanzhou 730000, Gansu, Peoples R China
[2] Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Shanghai 200032, Peoples R China
[3] Minist Educ, Key Lab Carcinogenesis & Canc Invas, Shanghai 200032, Peoples R China
[4] Univ Sydney, Westmead Millennium Inst, Dept Med, Storr Liver Unit, Westmead, NSW 2145, Australia
[5] Univ Sydney, Western Clin Sch, Westmead, NSW 2145, Australia
关键词
Cirrhosis; Pathogenesis; Hepatic stellate cells; Cytokine; miRNA; Animal model; Therapy; HEPATIC STELLATE CELLS; SINUSOIDAL ENDOTHELIAL-CELLS; PRIMARY BILIARY-CIRRHOSIS; GROWTH-FACTOR-BETA; MESENCHYMAL STEM-CELLS; NF-KAPPA-B; SALVIANOLIC ACID-B; HIGH-FAT DIET; RAT-LIVER; TGF-BETA;
D O I
10.3748/wjg.v20.i23.7312
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
Liver cirrhosis is the final pathological result of various chronic liver diseases, and fibrosis is the precursor of cirrhosis. Many types of cells, cytokines and miRNAs are involved in the initiation and progression of liver fibrosis and cirrhosis. Activation of hepatic stellate cells (HSCs) is a pivotal event in fibrosis. Defenestration and capillarization of liver sinusoidal endothelial cells are major contributing factors to hepatic dysfunction in liver cirrhosis. Activated Kupffer cells destroy hepatocytes and stimulate the activation of HSCs. Repeated cycles of apoptosis and regeneration of hepatocytes contribute to pathogenesis of cirrhosis. At the molecular level, many cytokines are involved in mediation of signaling pathways that regulate activation of HSCs and fibrogenesis. Recently, miRNAs as a post-transcriptional regulator have been found to play a key role in fibrosis and cirrhosis. Robust animal models of liver fibrosis and cirrhosis, as well as the recently identified critical cellular and molecular factors involved in the development of liver fibrosis and cirrhosis will facilitate the development of more effective therapeutic approaches for these conditions. (C) 2014 Baishideng Publishing Group Inc. All rights reserved.
引用
收藏
页码:7312 / 7324
页数:13
相关论文
共 201 条
[1]
MORPHOLOGY OF CIRRHOSIS [J].
ANTHONY, PP ;
ISHAK, KG ;
NAYAK, NC ;
POULSEN, HE ;
SCHEUER, PJ ;
SOBIN, LH .
JOURNAL OF CLINICAL PATHOLOGY, 1978, 31 (05) :395-414
[3]
Underestimation of Liver-Related Mortality in the United States [J].
Asrani, Sumeet K. ;
Larson, Joseph J. ;
Yawn, Barbara ;
Therneau, Terry M. ;
Kim, W. Ray .
GASTROENTEROLOGY, 2013, 145 (02) :375-+
[4]
Baroni GS, 1996, HEPATOLOGY, V23, P1189
[5]
Non-invasive tests in prediction of liver fibrosis in chronic hepatitis B and comparison with post-antiviral treatment results [J].
Basar, Omer ;
Yimaz, Baris ;
Ekiz, Fuat ;
Ginis, Zeynep ;
Altinbas, Akif ;
Aktas, Bora ;
Tuna, Yasar ;
Coban, Sahin ;
Delibas, Namik ;
Yuksel, Osman .
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2013, 37 (02) :152-158
[6]
Liver fibrosis [J].
Bataller, R ;
Brenner, DA .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (02) :209-218
[7]
Hepatic stellate cells as a target for the treatment of liver fibrosis [J].
Bataller, R ;
Brenner, DA .
SEMINARS IN LIVER DISEASE, 2001, 21 (03) :437-451
[8]
Progelatinase A is produced and activated by rat hepatic stellate cells and promotes their proliferation [J].
Benyon, RC ;
Hovell, CJ ;
Da Gaça, M ;
Jones, EH ;
Iredale, JP ;
Arthur, MJP .
HEPATOLOGY, 1999, 30 (04) :977-986
[9]
Progression of liver fibrosis in post-transplant hepatitis C: Mechanisms, assessment and treatment [J].
Berenguer, Marina ;
Schuppan, Detlef .
JOURNAL OF HEPATOLOGY, 2013, 58 (05) :1028-1041
[10]
BHUNCHET E, 1993, HEPATOLOGY, V18, P1450